Cutter & CO Brokerage, Inc. Pfizer Inc Transaction History

Cutter & CO Brokerage, Inc.

$406 Million
Q3 2024

A detailed history of Cutter & CO Brokerage, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Cutter & CO Brokerage, Inc. holds 112,284 shares of PFE stock, worth $3.08 Million. This represents 0.8% of its overall portfolio holdings.

Number of Shares

112,284

Previous 119,283 5.87%

Holding current value

$3.08 Million

Previous $3.34 Million 2.64%

% of portfolio

0.8%

Previous 0.88%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	SELL	$27.7 - $31.39 $193,872 - $219,698	-6,999 Reduced 5.87%	112,284 $3.25 Million
Q2 2024 Jul 31, 2024	BUY	$25.26 - $29.6 $41,931 - $49,136	1,660 Added 1.41%	119,283 $3.34 Million
Q1 2024 Apr 30, 2024	BUY	$25.89 - $29.73 $344,129 - $395,171	13,292 Added 12.74%	117,623 $3.26 Million
Q4 2023 Feb 01, 2024	BUY	$26.13 - $33.94 $2.25 Million - $2.92 Million	86,137 Added 473.44%	104,331 $3 Million
Q3 2023 Oct 31, 2023	BUY	$32.09 - $37.51 $77,016 - $90,024	2,400 Added 15.2%	18,194 $603,000
Q2 2023 Aug 01, 2023	BUY	$36.12 - $41.79 $18,060 - $20,895	500 Added 3.27%	15,794 $579,000
Q1 2023 May 09, 2023	BUY	$39.39 - $51.28 $35,411 - $46,100	899 Added 6.25%	15,294 $623,000
Q4 2022 Feb 03, 2023	SELL	$41.75 - $54.5 $3,423 - $4,469	-82 Reduced 0.57%	14,395 $737,000
Q3 2022 Nov 03, 2022	SELL	$43.76 - $53.42 $38,552 - $47,063	-881 Reduced 5.74%	14,477 $634,000
Q2 2022 Jul 28, 2022	SELL	$46.53 - $55.17 $51,601 - $61,183	-1,109 Reduced 6.73%	15,358 $805,000
Q1 2022 May 03, 2022	BUY	$45.75 - $56.69 $157,288 - $194,900	3,438 Added 26.39%	16,467 $852,000
Q4 2021 Feb 10, 2022	BUY	$41.32 - $61.25 $14,875 - $22,050	360 Added 2.84%	13,029 $769,000
Q3 2021 Nov 02, 2021	SELL	$39.25 - $50.42 $9,027 - $11,596	-230 Reduced 1.78%	12,669 $545,000
Q2 2021 Aug 09, 2021	BUY	$35.91 - $40.68 $3,016 - $3,417	84 Added 0.66%	12,899 $505,000
Q1 2021 May 11, 2021	SELL	$33.49 - $37.77 $52,210 - $58,883	-1,559 Reduced 10.85%	12,815 $464,000
Q4 2020 Feb 03, 2021	SELL	$33.47 - $42.56 $2,610 - $3,319	-78 Reduced 0.54%	14,374 $529,000
Q3 2020 Nov 05, 2020	BUY	$31.75 - $37.25 $24,034 - $28,198	757 Added 5.53%	14,452 $530,000
Q2 2020 Aug 10, 2020	BUY	$30.12 - $36.54 $8,252 - $10,011	274 Added 2.04%	13,695 $448,000
Q1 2020 May 05, 2020	SELL	$27.03 - $38.62 $598,417 - $855,008	-22,139 Reduced 62.26%	13,421 $438,000
Q4 2019 Feb 11, 2020	SELL	$32.92 - $37.36 $356,589 - $404,683	-10,832 Reduced 23.35%	35,560 $1.39 Million
Q3 2019 Nov 07, 2019	SELL	$32.49 - $42.13 $106,307 - $137,849	-3,272 Reduced 6.59%	46,392 $1.67 Million
Q2 2019 Jul 31, 2019	BUY	$36.98 - $41.52 $197,879 - $222,173	5,351 Added 12.08%	49,664 $2.15 Million
Q1 2019 Apr 23, 2019	SELL	$37.5 - $41.2 $32,850 - $36,091	-876 Reduced 1.94%	44,313 $1.88 Million
Q4 2018 Feb 07, 2019	BUY	$38.47 - $43.86 $90,558 - $103,246	2,354 Added 5.5%	45,189 $1.97 Million
Q3 2018 Oct 12, 2018	BUY	$34.47 - $41.81 $189,895 - $230,331	5,509 Added 14.76%	42,835 $1.89 Million
Q2 2018 Jul 30, 2018	SELL	$32.98 - $35.16 $11,312 - $12,059	-343 Reduced 0.91%	37,326 $1.35 Million
Q1 2018 May 11, 2018	SELL	$31.91 - $37.02 $2,712 - $3,146	-85 Reduced 0.23%	37,669 $1.34 Million
Q4 2017 Jan 30, 2018	SELL	$33.26 - $35.29 $584,544 - $620,221	-17,575 Reduced 31.76%	37,754 $1.37 Million
Q3 2017 Oct 23, 2017	SELL	$31.0 - $34.15 $72,819 - $80,218	-2,349 Reduced 4.07%	55,329 $1.98 Million
Q2 2017 Aug 07, 2017	BUY	N/A	57,678	57,678 $1.94 Million

Others Institutions Holding PFE

# of Institutions

3,253

Shares Held

3.72B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutter & CO Brokerage, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cutter & CO Brokerage, Inc. with notifications on news.

Account

Cutter & CO Brokerage, Inc. Pfizer Inc Transaction History